All analyses

Baxter International Inc. (BAX) Stock Analysis

Score D (Speculative)

Speculative · Grade D · Bearish

Healthcare · Medical Instruments & Supplies

$18.27

Fair Value

$14.42

-21.1%

Conviction

1/10

Quality

D

Classification

Speculative

Investment Thesis

Pre-profit company with limited upside (-21%) and/or quality concerns (grade D).

Pre-profit company with limited upside (-21%) and/or quality concerns (grade D).

For New Investors

Do not initiate a position. Wait for significant price improvement or catalysts.

For Current Holders

Consider reducing position. Downside outweighs upside at current price.

Buy if

  • Price drops below $10.09 (30% discount to FV)
  • Revenue continues to grow >30% QoQ
  • Path to profitability becomes visible (improving margins)

Sell if

  • Revenue growth decelerates below 15%
  • Cash runway drops below 6 months
  • Management significantly dilutes shareholders
  • Competitive moat weakens

Valuation

Pre-profit blend: ev_revenue $9.54 (50%), analyst_target $20.00 (30%), rule_of_40 $22.05 (20%)

Blended Fair Value

$14.42

Methods

ev_revenue, analyst_target, rule_of_40

Quality Analysis

D

40/120 points

PRE-PROFIT QUALITY: Grade D (40/100)

Quality Flags

  • LOW_GROWTH_FOR_PRE_PROFIT

Market Sentiment

Wall Street Consensus

$19.50

+6.8% Upside

13 analysts

Range: $15.00$27.00

Rating: Hold

Our model aligns with Wall Street consensus.

Trend & Technical

Bearish

Price ($18.27) is 9.2% below SMA 200 ($20.12). Bearish trend. Caution on entry.

Risk & Reward

Asymmetry Ratio

0.20:1

Expected Return

-25.8%

Bull Upside

+10.5%

Bear Downside

-52.6%

Risk/reward ratio of 0.2:1 (UNFAVORABLE). Pre-profit valuations carry wider ranges.

Verdict: Unfavorable

Scenario Analysis

Bear

Base

Bull

Buy Zone & Action Plan

See exact entry zones, stop-loss levels, and a personalized action plan.

Access free

AI Executive Summary

Get a detailed AI-written breakdown of the investment thesis, risks, and catalysts.

Access free

Technical Analysis

RSI, MACD, moving averages, trend signals, and momentum indicators.

Access free

Ask AI about this stock

Chat with our AI analyst to ask questions about valuation, risks, or comparisons.

Access free

Frequently Asked Questions

What is the fair value of BAX?

Based on our multi-method conviction analysis, the estimated fair value of Baxter International Inc. (BAX) is $14.42. This is calculated by blending ev_revenue, analyst_target, rule_of_40 and applying a quality premium of 0% based on the company's fundamentals. The confidence level of this estimate is moderate.

Is BAX a buy, sell, or hold?

BAX currently has a SPECULATIVE_AVOID rating with a conviction score of 1/10. Pre-profit company with limited upside (-21%) and/or quality concerns (grade D). Do not initiate a position. Wait for significant price improvement or catalysts..

Is BAX a high-quality stock?

Baxter International Inc. has a quality grade of D (40/120 points), rated as PRE-PROFIT QUALITY: Grade D (40/100). Key metrics include ROE of —%, ROIC-WACC spread of —%, and D/E ratio of 1.6x.

What type of stock is BAX?

BAX is classified as a "speculative" in our framework. Low dividend (reinvesting): 2.0%, Mature growth: 3.2%, High debt: D/E 1.6x, Dividend paying: 2.0%, Consistent FCF: 3/3 years positive

What do Wall Street analysts say about BAX?

13 Wall Street analysts have a consensus price target of $19.50 for BAX, representing +6.8% upside. Targets range from $15.00 to $27.00. The consensus recommendation is "Hold". Our model aligns with Wall Street consensus.

What are the risks of investing in BAX?

The risk/reward asymmetry ratio for BAX is 0.20:1, rated as Unfavorable. Risk/reward ratio of 0.2:1 (UNFAVORABLE). Pre-profit valuations carry wider ranges. The expected return is -25.8%, with bull case upside of +10.5% and bear case downside of -52.6%.

What is the current trend for BAX?

BAX is in a bearish trend. Price ($18.27) is 9.2% below SMA 200 ($20.12). Bearish trend. Caution on entry. The technical score is —/100.

Related Stock Analyses

Best Stocks to Buy

Get the complete analysis

Scenario targets, buy zones, action plan, executive summary, technical analysis, and AI chat. All free.

Last updated: May 19, 2026 · Framework version 3.7

This analysis is for informational purposes only and should not be considered financial advice. Always do your own research before making investment decisions.